Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells.
Bruno
E
E
Department of Medicine of the Indiana University School of Medicine, Indianapolis 46202-5121.
Briddell
R A
RA
Cooper
R J
RJ
Hoffman
R
R
D018952:Antigens, CD34; D000943:Antigens, Differentiation / Q000276:immunology; D001854:Bone Marrow Cells; D002455:Cell Division; D002478:Cells, Cultured; D006684:HLA-DR Antigens / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology; D006801:Humans; D017370:Interleukin-11; D007377:Interleukin-3 / Q000494:pharmacology; D007378:Interleukins / Q000494:pharmacology*; D008533:Megakaryocytes / Q000166:cytology* / Q000276:immunology; D011994:Recombinant Proteins / Q000494:pharmacology
D018952:Antigens, CD34; D000943:Antigens, Differentiation; D006684:HLA-DR Antigens; D017370:Interleukin-11; D007377:Interleukin-3; D007378:Interleukins; D011994:Recombinant Proteins